Sara Charleer

1.0k total citations
21 papers, 693 citations indexed

About

Sara Charleer is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Surgery. According to data from OpenAlex, Sara Charleer has authored 21 papers receiving a total of 693 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Endocrinology, Diabetes and Metabolism, 14 papers in Genetics and 13 papers in Surgery. Recurrent topics in Sara Charleer's work include Diabetes Management and Research (20 papers), Diabetes and associated disorders (14 papers) and Pancreatic function and diabetes (13 papers). Sara Charleer is often cited by papers focused on Diabetes Management and Research (20 papers), Diabetes and associated disorders (14 papers) and Pancreatic function and diabetes (13 papers). Sara Charleer collaborates with scholars based in Belgium, United States and Denmark. Sara Charleer's co-authors include Chantal Mathieu, Pieter Gillard, Frank Nobels, Christophe De Block, Steffen Fieuws, Liesbeth Van Huffel, Bart Keymeulen, Chris Vercammen, Régis Radermecker and Youri Taes and has published in prestigious journals such as The Lancet, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

Sara Charleer

20 papers receiving 660 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sara Charleer Belgium 10 655 418 399 25 22 21 693
Ingrid Schütz-Fuhrmann Austria 7 507 0.8× 325 0.8× 377 0.9× 14 0.6× 26 1.2× 15 568
Yongjin Xu United States 11 442 0.7× 272 0.7× 247 0.6× 14 0.6× 30 1.4× 26 470
Emma Walkinshaw United Kingdom 13 575 0.9× 367 0.9× 387 1.0× 50 2.0× 20 0.9× 19 629
Ryan Bailey United States 9 342 0.5× 208 0.5× 209 0.5× 20 0.8× 22 1.0× 28 390
G Faber-Heinemann Germany 4 378 0.6× 248 0.6× 241 0.6× 11 0.4× 16 0.7× 5 409
Claudia Graham United States 12 471 0.7× 216 0.5× 232 0.6× 26 1.0× 44 2.0× 15 544
Isabelle Isa Kristin Steineck Denmark 9 447 0.7× 258 0.6× 253 0.6× 30 1.2× 16 0.7× 12 483
Emily Jost United States 7 510 0.8× 356 0.9× 412 1.0× 21 0.8× 13 0.6× 13 548
Harald Kojzar Austria 12 478 0.7× 287 0.7× 360 0.9× 30 1.2× 13 0.6× 33 570
Chantal McMahon United States 5 431 0.7× 261 0.6× 241 0.6× 20 0.8× 8 0.4× 6 461

Countries citing papers authored by Sara Charleer

Since Specialization
Citations

This map shows the geographic impact of Sara Charleer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Charleer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Charleer more than expected).

Fields of papers citing papers by Sara Charleer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Charleer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Charleer. The network helps show where Sara Charleer may publish in the future.

Co-authorship network of co-authors of Sara Charleer

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Charleer. A scholar is included among the top collaborators of Sara Charleer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Charleer. Sara Charleer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Keymeulen, Bart, Christophe De Block, Liesbeth Van Huffel, et al.. (2025). One-year real-world benefits of Tandem Control-IQ technology on glucose management and person-reported outcomes in adults with type 1 diabetes: a prospective observational cohort study. Diabetologia. 68(5). 948–960. 6 indexed citations
2.
Steenackers, Nele, Thomas Sparsø, Sara Charleer, et al.. (2024). Health‐related quality of life of people with type 1 diabetes: An IMI2 SOPHIA post hoc analysis of FUTURE and ADJUNCT ‐ ONE. Diabetes Obesity and Metabolism. 26(11). 4897–4904.
3.
4.
David, Karel, Ann Swillen, Elfi Vergaelen, et al.. (2024). Endocrine manifestations in adults with 22q11.2 deletion syndrome: a retrospective single-center cohort study. Journal of Endocrinological Investigation. 47(7). 1827–1836. 3 indexed citations
5.
6.
7.
Charleer, Sara, Steffen Fieuws, Christophe De Block, et al.. (2023). Effect of switching from intermittently scanned to real-time continuous glucose monitoring in adults with type 1 diabetes: 24-month results from the randomised ALERTT1 trial. The Lancet Diabetes & Endocrinology. 11(2). 96–108. 27 indexed citations
8.
Charleer, Sara, et al.. (2023). The Relationship Between Glycated Hemoglobin and Time in Range in a Pediatric Population. Diabetes Technology & Therapeutics. 26(5). 346–350. 2 indexed citations
9.
Charleer, Sara, Steffen Fieuws, Christophe De Block, et al.. (2022). The Impact of Baseline User Characteristics on the Benefits of Real-Time Versus Intermittently Scanned Continuous Glucose Monitoring in Adults With Type 1 Diabetes: Moderator Analyses of the ALERTT1 Trial. Journal of Diabetes Science and Technology. 18(3). 660–666. 5 indexed citations
10.
Charleer, Sara, Kristien J. Ledeganck, Sara Van Aken, et al.. (2022). Effect of nationwide reimbursement of real-time continuous glucose monitoring on HbA1c, hypoglycemia and quality of life in a pediatric type 1 diabetes population: The RESCUE-pediatrics study. Frontiers in Pediatrics. 10. 991633–991633. 5 indexed citations
11.
Charleer, Sara, Steffen Fieuws, Christophe De Block, et al.. (2021). Comparing real-time and intermittently scanned continuous glucose monitoring in adults with type 1 diabetes (ALERTT1): a 6-month, prospective, multicentre, randomised controlled trial. The Lancet. 397(10291). 2275–2283. 107 indexed citations
12.
Charleer, Sara, Eveline Dirinck, Kristien J. Ledeganck, et al.. (2021). Relationship Between Time in Range, Glycemic Variability, HbA1c, and Complications in Adults With Type 1 Diabetes Mellitus. The Journal of Clinical Endocrinology & Metabolism. 107(2). e570–e581. 80 indexed citations
13.
Charleer, Sara, et al.. (2021). Diabetes Knowledge and Metabolic Control in Type 1 Diabetes Starting With Continuous Glucose Monitoring: FUTURE-PEAK. The Journal of Clinical Endocrinology & Metabolism. 106(8). e3037–e3048. 10 indexed citations
14.
15.
Charleer, Sara, Eveline Dirinck, Frida Peiffer, et al.. (2021). Glucose control using fast‐acting insulin aspart in a real‐world setting: A 1 ‐year, two‐centre study in people with type 1 diabetes using continuous glucose monitoring. Diabetes Obesity and Metabolism. 23(12). 2716–2727. 11 indexed citations
16.
Gillard, Pieter, Sara Charleer, Kristien J. Ledeganck, et al.. (2020). Quality of life versus glycaemic variability and time in range in people with type 1 diabetes : sub study of the RESCUE-trial. Ghent University Academic Bibliography (Ghent University). 1 indexed citations
17.
Charleer, Sara, Christophe De Block, Frank Nobels, et al.. (2020). Sustained Impact of Real-time Continuous Glucose Monitoring in Adults With Type 1 Diabetes on Insulin Pump Therapy: Results After the 24-Month RESCUE Study. Diabetes Care. 43(12). 3016–3023. 30 indexed citations
18.
19.
Charleer, Sara, Chantal Mathieu, Frank Nobels, et al.. (2018). Effect of Continuous Glucose Monitoring on Glycemic Control, Acute Admissions, and Quality of Life: A Real-World Study. The Journal of Clinical Endocrinology & Metabolism. 103(3). 1224–1232. 143 indexed citations
20.
Charleer, Sara, Chantal Mathieu, Frank Nobels, & Pieter Gillard. (2018). Accuracy and precision of flash glucose monitoring sensors inserted into the abdomen and upper thigh compared with the upper arm. Diabetes Obesity and Metabolism. 20(6). 1503–1507. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ingrid Schütz-Fuhrmann Breakdown of academic impact, for papers by Yongjin Xu Breakdown of academic impact, for papers by Emma Walkinshaw Breakdown of academic impact, for papers by Ryan Bailey Breakdown of academic impact, for papers by G Faber-Heinemann Breakdown of academic impact, for papers by Claudia Graham Breakdown of academic impact, for papers by Isabelle Isa Kristin Steineck Breakdown of academic impact, for papers by Emily Jost Breakdown of academic impact, for papers by Harald Kojzar Breakdown of academic impact, for papers by Chantal McMahon
Rankless by CCL
2026